USEUROPEAFRICAASIA 中文双语Français
Home / Mosaic

Genentech costs hit Roche earnings

China Daily | Updated: 2009-07-24 08:04

Genentech costs hit Roche earnings

An employee checks capsules of Roche's influenza drug Tamiflu. Bloomberg News

BASEL, Switzerland: Roche, the maker of the Tamiflu flu drug, missed forecasts with a 29 percent drop in first-half net profit, hit by costs related to its $47 billion acquisition of Genentech.

Genentech costs hit Roche earnings

Today's Top News

Editor's picks

Most Viewed

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US